METHODS AND COMPOSITIONS FOR TREATING NON-ALCOHOLIC FATTY LIVER DISEASE WITH DOCOSAHEXAENOIC ACID AND N-ACETYL L-CYSTEINE

摘要

The present invention is related to methods and compositions for treating non-alcoholic fatty liver disease (NAFLD), and methods of enhancing liver health and/or liver function, in a subject in need thereof, the methods comprising administering to the subject about 200 mg to about 12 g of docosahexaenoic acid (DHA) substantially free of eicosapentaenoic acid (EPA), and an effective amount of N-acetyl L-cysteine (NAC).